Andreas Gollner
@andreas-gollner.bsky.social
Medicinal chemistry, drug hunter, SLCs, TPD, PPIs. Mountainbike.
Great to see our First Disclosure of Brigimadlin, a highly potent MDM2 inhibitor highlighted and on the cover of Molecular Cancer Therapeutics @theaacr.bsky.social aacrjournals.org/mct/article/.... Congratulations to the team at @boehringer.bsky.social
December 4, 2024 at 9:34 PM
Great to see our First Disclosure of Brigimadlin, a highly potent MDM2 inhibitor highlighted and on the cover of Molecular Cancer Therapeutics @theaacr.bsky.social aacrjournals.org/mct/article/.... Congratulations to the team at @boehringer.bsky.social